As of 2026-04-11, the Relative Valuation of Viking Therapeutics Inc (VKTX) is (68.08) USD. This relative valuation is based on P/E multiples. With the latest stock price at 34.26 USD, the upside of Viking Therapeutics Inc based on Relative Valuation is -298.7%.
The range of the Relative Valuation is (64.43) - (68.47) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 20.3x - 24.5x | 22.4x |
| Forward P/E multiples | 20.7x - 22.0x | 21.4x |
| Fair Price | (64.43) - (68.47) | (68.08) |
| Upside | -288.1% - -299.9% | -298.7% |
| Date | P/E |
| 2026-04-09 | -11.23 |
| 2026-04-08 | -10.82 |
| 2026-04-07 | -10.83 |
| 2026-04-06 | -10.90 |
| 2026-04-02 | -11.18 |
| 2026-04-01 | -10.59 |
| 2026-03-31 | -10.45 |
| 2026-03-30 | -9.61 |
| 2026-03-27 | -10.45 |
| 2026-03-26 | -11.00 |
| 2026-03-25 | -10.67 |
| 2026-03-24 | -10.34 |
| 2026-03-23 | -10.46 |
| 2026-03-20 | -10.39 |
| 2026-03-19 | -10.90 |
| 2026-03-18 | -10.78 |
| 2026-03-17 | -11.42 |
| 2026-03-16 | -11.57 |
| 2026-03-13 | -11.45 |
| 2026-03-12 | -11.40 |
| 2026-03-11 | -11.49 |
| 2026-03-10 | -11.14 |
| 2026-03-09 | -10.80 |
| 2026-03-06 | -10.60 |
| 2026-03-05 | -10.12 |
| 2026-03-04 | -10.33 |
| 2026-03-03 | -10.26 |
| 2026-03-02 | -10.71 |
| 2026-02-27 | -10.87 |
| 2026-02-26 | -10.59 |
| 2026-02-25 | -10.64 |
| 2026-02-24 | -10.84 |
| 2026-02-23 | -11.07 |
| 2026-02-20 | -9.97 |
| 2026-02-19 | -9.99 |
| 2026-02-18 | -9.69 |
| 2026-02-17 | -9.78 |
| 2026-02-13 | -9.32 |
| 2026-02-12 | -9.80 |
| 2026-02-11 | -9.17 |
| 2026-02-10 | -9.24 |
| 2026-02-09 | -9.41 |
| 2026-02-06 | -9.14 |
| 2026-02-05 | -8.45 |
| 2026-02-04 | -9.50 |
| 2026-02-03 | -9.45 |
| 2026-02-02 | -9.61 |
| 2026-01-30 | -9.33 |
| 2026-01-29 | -9.72 |
| 2026-01-28 | -9.77 |